A midposition NOTCH3 truncation in inherited cerebral small vessel disease may affect the protein interactome

• Published in: The Journal of biological chemistry 2023-01, Vol.299 (1), p.102772-102772, Article 102772
• Main Authors: Lee, Soo Jung, Zhang, Xiaojie, Xu, Gang, Borjigin, Jimo, Wang, Michael M.
• Format: Article
• Language: English
• Subjects: Asp-Pro bond; Brain - metabolism; CADASIL; CADASIL - genetics; CADASIL - pathology; Cerebral Small Vessel Diseases - genetics; Cerebral Small Vessel Diseases - pathology; Humans; Mutation; nonenzymatic cleavage; NOTCH3; Protein Array Analysis; Protein Binding; protein interactions; Receptor, Notch3 - genetics; Receptor, Notch3 - metabolism; Recombinant Proteins - genetics; Recombinant Proteins - metabolism
• ISSN: 0021-9258; 1083-351X
• DOI: 10.1016/j.jbc.2022.102772

Mutations in NOTCH3 underlie cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), the most common inherited cerebral small vessel disease. Two cleavages of NOTCH3 protein, at Asp80 and Asp121, were previously described in CADASIL pathological samples. Using monoclonal antibodies developed against a NOTCH3 neoepitope, we identified a third cleavage at Asp964 between an Asp-Pro sequence. We characterized the structural requirements for proteolysis at Asp964 and the vascular distribution of the cleavage event. A proteome-wide analysis was performed to find proteins that interact with the cleavage product. Finally, we investigated the biochemical determinants of this third cleavage event. Cleavage at Asp964 was critically dependent on the proline adjacent to the aspartate residue. In addition, the cleavage product was highly enriched in CADASIL brain tissue and localized to the media of degenerating arteries, where it deposited with the two additional NOTCH3 cleavage products. Recombinant NOTCH3 terminating at Asp964 was used to probe protein microarrays. We identified multiple molecules that bound to the cleaved NOTCH3 more than to uncleaved protein, suggesting that cleavage may alter the local protein interactome within disease-affected blood vessels. The cleavage of purified NOTCH3 protein at Asp964 in vitro was activated by reducing agents and NOTCH3 protein; cleavage was inhibited by specific dicarboxylic acids, as seen with cleavage at Asp80 and Asp121. Overall, we propose homologous redox-driven Asp-Pro cleavages and alterations in protein interactions as potential mechanisms in inherited small vessel disease; similarities in protein cleavage characteristics may indicate common biochemical modulators of pathological NOTCH3 processing.